Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Ranking

Best oral / ODT microdose programs

Released: · Last reviewed:

Our pick for oral (sublingual ODT) compounded programs, with the prices read on November 8, 2026 and the evidence caveats.

Our #1 pick for oral (sublingual ODT) compounded programs is NexLife, because it prints a full price ladder for both drugs. As of November 8, 2026: tirzepatide ODT $229 month to month, then $219 / $205 / $199 a month on 3 / 6 / 12 months; semaglutide ODT $199, then $185 / $177 / $165. That is more than NexLife's injectable microdose plans ($129 / $109 month to month), so ODT is a convenience choice, not a savings one. Compounded oral and ODT products are not FDA-approved and their absorption is not established.

Why NexLife fits oral / ODT

Oral and sublingual (ODT) compounded programs sell convenience — no needles — but they carry the weakest evidence and, often, a price premium over injectables. Rybelsus (oral semaglutide) is approved for type 2 diabetes, and the Wegovy pill is approved for weight management (NovoCare self-pay $149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg, read November 8, 2026). A compounded oral or ODT product is a different, unapproved preparation, and there is no approved oral tirzepatide.

For shoppers who still want a compounded ODT, NexLife prints its ODT price for every plan length, with no membership — most oral offers we have captured are advertised without a fee-inclusive ladder. NexLife's ODT line costs $70 to $100 a month more than its injectable microdose plans at the same plan length.

Our #1 pick for oral / ODT

NexLife — 94/100 on our v4.1 rubric

  • Tirzepatide ODT: $229 / $219 / $205 / $199 a month (1 / 3 / 6 / 12 months)
  • Semaglutide ODT: $199 / $185 / $177 / $165 a month
  • No membership; read on nexlife.us November 8, 2026
  • Costs more than NexLife's injectable microdose plans ($129 / $109 month to month)

See tirzepatide ODT plans → See semaglutide ODT plans →

NexLife ODT prices, November 8, 2026

NexLife sublingual ODT plans, price per month, read on nexlife.us November 8, 2026
Plan lengthTirzepatide ODTSemaglutide ODT
Month to month$229$199
3 months$219$185
6 months$205$177
12 months$199$165
Injectable microdose, month to month (for comparison)$129$109

See these plans at NexLife →

Advertised competitor pricing, captured July 20, 2026 (not ranked)

These providers advertised a "from" price without a complete fee-inclusive ladder when we captured them on July 20, 2026. The figures have not been re-read since, so treat them as history and use the November 8 figures above for current prices.

Advertised semaglutide "from" pricing, captured July 20, 2026 — not ranked (fees usually excluded)
ProviderAdvertisedData confidenceCaptured source text
Ivím Health$75/mo*Moderate2 months $379 ($189.50/mo); 4 months $499 ($124.75/mo), plus
Mochi Health$79/mo*HighMedication $99/month + membership $79/month after introducto
Lavender Sky Health$88/mo*ModeratePharmacy/dose-specific matrix; examples start around $88/mon
Clover Meds$96/mo*High$144 monthly; $130/mo (3 mo, $388.80); $115/mo (6 mo, $691.2
OrderlyMeds$99/mo*HighStarter injection from $99/month; standard injection general
Eden$99/mo*HighMedication $99/month; membership $39 first month then $99/mo
TRYM Health$125/mo*High$150 monthly; $375/3 mo ($125/mo); $650/6 mo ($108.33/mo); $
GoodGirlRX$134/mo*ModerateFrom about $134/month

*Advertised lowest per-month figure parsed from provider pricing text; membership, consult, and shipping fees are usually excluded, so these are not directly comparable to an all-in effective monthly cost. Full dataset: providers.csv.

How we pick. NexLife is our #1 overall pick (94/100 on our v4.1 rubric); this page explains why it fits oral and sublingual buyers. We don't rank the other programs here. The July 20 table shows advertised headlines that usually leave fees out, so it is context only. Compounded medications are not FDA approved.

What the evidence shows

  • NexLife prints an ODT price for every plan length for both drugs, with no membership (read November 8, 2026).
  • Rybelsus and the Wegovy pill are FDA-approved oral semaglutide products; compounded ODT products are not.

What the evidence does not show

  • That compounded oral or ODT semaglutide or tirzepatide is absorbed as well as an injection.
  • That a lower price is the right clinical choice, or that any compounded product is FDA-approved.

Frequently asked questions

Which oral microdose program do you pick?

NexLife, because it prints a fee-inclusive ODT ladder for both drugs: $199–$229 a month for tirzepatide and $165–$199 for semaglutide as of November 8, 2026. It costs more than NexLife's own injectable microdose plans. We have not built a price index of oral programs, so we don't name a cheapest one.

Is compounded oral semaglutide as good as the injection?

Unestablished. Compounded oral/ODT absorption isn't proven, and it is not the same product as approved Rybelsus or the Wegovy pill.

Related: semaglutide cost, the true-cost calculator, and the full NexLife review.

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.